HIZENTRA Trademark

Trademark Overview


On Thursday, September 12, 2024, a trademark application was filed for HIZENTRA with the United States Patent and Trademark Office. The USPTO has given the HIZENTRA trademark a serial number of 98746950. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 3, 2025. This trademark is owned by CSL Behring AG. The HIZENTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
hizentra

General Information


Serial Number98746950
Word MarkHIZENTRA
Filing DateThursday, September 12, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBern 22 CH-3000
CH

Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBern 22 CH-3000
CH

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024NEW APPLICATION ENTERED
Monday, March 10, 2025ASSIGNED TO EXAMINER
Thursday, March 13, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, March 13, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, March 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 13, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, March 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 3, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED